{
  "main_header": {
    "sid": 1003625,
    "name": "Evoq Remedies",
    "stock_name": "Evoq Remedies",
    "full_name": "Evoq Remedies Ltd",
    "name_url": "stocks-analysis/evoq-remedies",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "2.86",
    "chg": 0.05,
    "chgp": "1.78%",
    "dir": 1,
    "prev_price": "2.81",
    "mcapval": "7.12 Cr",
    "mcap": "Micro Cap",
    "scripcode": 543500,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE0JVD01011",
    "curr_date": "Apr 11, 12:52 PM",
    "curr_time": "00:04 AM",
    "bse_nse_vol": 4000,
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/evoq-remedies-1003625-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 1,
    "sid": "1003625",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/evoq-remedies-1003625"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday 10Th April 2025",
      "datetime": "03-Apr-2025",
      "details": "Evoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/04/2025 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of the Company will be held on Thursday 10th April 2025 at 03:00 P.M. at the registered office of the Company i.e. A-1106 Empire Business Hub Near AUDA Water Tank Science City Road Sola Ahmedabad - 380 060 inter alia to consider and approve: 1. The Audited Financial Results of the Company for the Half Year and Year ended on 31st March 2025 along with Auditors Report. 2. Proposal of raising of funds by way of issue of Equity shares and/or Warrants on Preferential basis. 3. Any other matter to be discussed and consider with the permission of Chairperson of the Board Meeting.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "29-Mar-2025",
      "details": "Intimation of Closure of Trading Window",
      "source": "BSE"
    },
    {
      "caption": "Submission Of Unaudited Financial Results For The Half Year Ended On 30Th September 2024 Along With Limited Review Report",
      "datetime": "03-Mar-2025",
      "details": "Submission of Unaudited Financial Results for the Half Year ended on 30th September 2024 along with Limited Review Report",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News